Discontinued Operations (Details) - Schedule of Remaining Unresolved Components of Contingent Consideration Receivable	Jun. 30, 2024 USD ($)
Schedule of Remaining Unresolved of Contingent Consideration Receivable [Abstract]
IPO Share Consideration	$ 1,463,518
Physician Advance Consideration	199,645
Remaining contingent sale consideration receivable	$ 1,663,163

Remaining contingent sale consideration receivable.

No definition available.

Name:	hlyk_ContingentSalesConsiderationReceivableLongTermPortion
Namespace Prefix:	hlyk_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant